skip to primary navigationskip to content

Postdoctoral Research Assistant - Immunology and B-cell Repertoire Sequencing

Oxford Vaccine Group, CCVTM, Churchill Hospital, Oxford

Postdoctoral Research Assistant - Immunology and B-cell Repertoire Sequencing
Oxford Vaccine Group, CCVTM, Churchill Hospital, Oxford
Grade 7: £31,076 - £38,183 p.a.

The University of Oxford, Department of Paediatrics is seeking to appoint a suitably qualified Postdoctoral Research Assistant at the Oxford Vaccine Group (OVG), based at the Centre of Clinical Vaccinology and Tropical Medicine (CCVTM).

The overall objective of the post is to develop insights into the immune response to vaccines that will drive the development of the next generation of vaccines.

The postholder will develop immunological assays applied to a variety of clinical trials samples, with a specific focus on B-cell receptor (BCR) repertoire sequencing and the application of proteomics approaches to decipher BCR repertoire after vaccination. You will be responsible for developing projects using samples from clinical trials including ongoing studies of pertussis vaccines. You will manage your own research projects, supervise junior staff, and coordinate internal and external project collaborations.

You will have a relevant PhD and possess experience and a good knowledge of both immunological techniques and high-throughput sequencing technologies. You will have a working knowledge of statistics and command line data analysis. You will be self-driven, highly motivated and have excellent organisational and interpersonal skills as the post involves collaboration within several groups and consortia.

This is a full-time post offered for 36 months in the first instance.

For an informal discussion, please contact Dominic Kelly using the email address below.

The closing date for applications is 12.00 noon on Thursday 20 July 2017.

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2019.

Fibroblast

‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more